Persistent URL of this record https://hdl.handle.net/1887/105955
In Collections
This item can be found in the following collections:
![LEUKEMIC CD52 NEGATIVE GPI DEFECTIVE CLONES ARE COMMON IN ALL, ESCAPE ALEMTUZUMAB THERAPY, BUT ARE SENSITIVE TO RITUXIMAB MEDIATED COMPLEMENT DEPENDENT CYTOTOXICITY: RATIONALE FOR COMBINATION THERAPY](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
LEUKEMIC CD52 NEGATIVE GPI DEFECTIVE CLONES ARE COMMON IN ALL, ESCAPE ALEMTUZUMAB THERAPY, BUT ARE SENSITIVE TO RITUXIMAB MEDIATED COMPLEMENT DEPENDENT CYTOTOXICITY: RATIONALE FOR COMBINATION THERAPY
- All authors
- Nijmeijer, B.; Schie, M. van; Goselink, H.; Halkes, C.; Falkenburg, J.
- Date
- 2010-06-30
- Title of host publication
- Haematologica
- Volume
- 95
- Pages
- 467 - 467